105 related articles for article (PubMed ID: 26905319)
1. Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, Cameroon.
Luma HN; Eloumou SA; Malongue A; Temfack E; Noah DN; Donfack-Sontsa O; Ditah IC
Int J Infect Dis; 2016 Apr; 45():53-8. PubMed ID: 26905319
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
[TBL] [Abstract][Full Text] [Related]
4. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
5. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
6. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
7. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
8. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
[TBL] [Abstract][Full Text] [Related]
9. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
12. Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study.
Seong MH; Kil H; Kim YS; Bae SH; Lee YJ; Lee HC; Kang BH; Jeong SH
J Med Virol; 2013 Oct; 85(10):1724-33. PubMed ID: 23813472
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis-C virus and hepatoma].
Zala G; Havelka J; Altorfer J; Joller-Jemelka HJ; Risti B; Meier B; Schmid M; Bühler H
Schweiz Med Wochenschr; 1992 Feb; 122(6):194-7. PubMed ID: 1311125
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
16. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece.
Savvas SP; Koskinas J; Sinani C; Hadziyannis A; Spanou F; Hadziyannis SJ
J Viral Hepat; 2005 Sep; 12(5):551-7. PubMed ID: 16108773
[TBL] [Abstract][Full Text] [Related]
17. Incidence and factors associated with seroconversion to hepatitis C virus seropositivity amongst patients on maintenance hemodialysis, Douala-Cameroon.
Halle MP; Larry T; Okalla C; Mefo'o N; Hermine F; Ashuntantang G
Saudi J Kidney Dis Transpl; 2018; 29(4):939-945. PubMed ID: 30152433
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
[TBL] [Abstract][Full Text] [Related]
19. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
20. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]